Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$30.43 - $53.43 $446,225 - $783,497
14,664 Added 35.3%
56,200 $2.26 Million
Q1 2024

May 10, 2024

SELL
$22.09 - $35.41 $271,618 - $435,401
-12,296 Reduced 22.84%
41,536 $1.47 Million
Q4 2023

Feb 07, 2024

SELL
$14.28 - $31.03 $1.16 Million - $2.52 Million
-81,177 Reduced 60.13%
53,832 $1.59 Million
Q3 2023

Nov 09, 2023

SELL
$19.33 - $36.22 $3.08 Million - $5.78 Million
-159,503 Reduced 54.16%
135,009 $2.8 Million
Q2 2023

Aug 09, 2023

BUY
$24.18 - $42.46 $1.21 Million - $2.12 Million
49,929 Added 20.41%
294,512 $7.23 Million
Q1 2023

May 12, 2023

BUY
$35.86 - $46.5 $7.43 Million - $9.63 Million
207,203 Added 554.32%
244,583 $9.93 Million
Q4 2022

Feb 09, 2023

SELL
$35.49 - $56.15 $194,875 - $308,319
-5,491 Reduced 12.81%
37,380 $1.68 Million
Q3 2022

Nov 10, 2022

SELL
$43.76 - $68.97 $2.85 Million - $4.49 Million
-65,122 Reduced 60.3%
42,871 $2.05 Million
Q2 2022

Aug 12, 2022

SELL
$53.22 - $123.09 $4.12 Million - $9.53 Million
-77,415 Reduced 41.75%
107,993 $6.39 Million
Q1 2022

May 13, 2022

BUY
$101.89 - $150.09 $7.68 Million - $11.3 Million
75,358 Added 68.48%
185,408 $21.6 Million
Q4 2021

Feb 09, 2022

BUY
$118.18 - $153.21 $943,076 - $1.22 Million
7,980 Added 7.82%
110,050 $16.6 Million
Q3 2021

Nov 12, 2021

SELL
$93.51 - $129.4 $3.29 Million - $4.55 Million
-35,191 Reduced 25.64%
102,070 $12.2 Million
Q2 2021

Aug 12, 2021

BUY
$77.0 - $100.19 $4.99 Million - $6.49 Million
64,813 Added 89.46%
137,261 $13.4 Million
Q1 2021

May 14, 2021

BUY
$81.28 - $104.34 $741,680 - $952,102
9,125 Added 14.41%
72,448 $6.39 Million
Q4 2020

Feb 25, 2021

BUY
$86.4 - $121.75 $5.47 Million - $7.71 Million
63,323 New
63,323 $6.06 Million

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.34B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.